BusinessAXIM® Biotechnologies, Inc. Publishes Product Pipeline Chart for Pharmaceutical Clinical Trials Program in Cannabinoid R&DBy Nasdaq OMXNov 3, 2016, 1:01 PM UTC
BusinessAXIM® Biotechnologies, Inc. Publishes Product Pipeline Chart for Pharmaceutical Clinical Trials Program in Cannabinoid R&DBy Nasdaq OMXNov 3, 2016, 1:01 PM UTC
BusinessAXIM® Biotechnologies, Inc. Secures Funding to Continue Pharmaceutical Clinical Trials Program in Cannabinoid Research and Development for Multiple IndicationsBy Nasdaq OMXOct 26, 2016, 1:04 PM UTC
BusinessAXIM® Biotech Signs Exclusive Distribution Agreement With Israel’s Rafa PharmaceuticalsBy Nasdaq OMXSep 19, 2016, 1:00 PM UTC
BusinessAXIM Biotechnologies Expands Executive Team and Advisory Board With Finance and Pro Sports Leaders: Seth Yakatan and Marvin WashingtonBy Nasdaq OMXJan 28, 2016, 1:59 PM UTC
BusinessAXIM Biotechnologies Featured in Marijuana Documentary “Cannabis is Medicine”By Nasdaq OMXJan 13, 2016, 2:15 PM UTC
BusinessMedical Marijuana, Inc. Investment – AXIM Biotech – Featured by Reuters; Cannabis "Gum to Treat Multiple Sclerosis" Pain and SpasticityBy Nasdaq OMXJan 6, 2016, 2:00 PM UTC
